Molecular Medicine and Gene Therapy
Molecular Medicine and Gene Therapy is located at the Biomedical Center (BMC), Lund University, Sweden. This Department is a joint venture between the Medical Faculty, Lund University and the Hematology Clinic at Lund University Hospital.
The laboratory investigates the properties of blood stem cells and is developing cell and gene therapy for blood disorders. The development of cell and gene therapy is considered important for many genetic disorders and cancer, disorders that remain incurable at present. Within the laboratory, there are eight independent research groups that collaborate closely to understand the regulation of blood stem cells.
Six of these research groups are members of the Hemato Linné excellence program in blood stem cell biology (Linnaeus Program) funded by The Swedish Research Council and Lund University and several of the groups are also members of STEMTHERAPY, a strategic research and infrastructure program, also supported by The Swedish Research Council.
Kári Stefánsson, MD, Dr Med, CEO of deCODE Genetics is visiting Lund on May 27,2013. He will give a seminar in Belfrage lecture hall, BMC D15, at 14:00.
Title: Flaws in the bluprint: Common and not so common diseases of man.
New paper in Blood. Identification of the chemokine CCL28 as a growth and survival factor for human hematopoietic stem- and progenitor cells, published by the Larsson group.
A symposium joining scientists from HERM (Center for Hematology and Regenerative Medicine, Karolinska Insitutet), Hemato-Linné and StemTherapy.
February 11-12, 2013,
Arranged by Hemato-Linné and StemTherapy in Lund.